Methylprednisolone: Difference between revisions
Jump to navigation
Jump to search
NCLEX nursing pharmacology monographs — batch import |
Add medication infobox (Drugbox) to monographs |
||
| Line 1: | Line 1: | ||
{{Drugbox | |||
| name = Methylprednisolone | |||
| brand = Medrol, Solu-Medrol | |||
| therapeutic = Anti-inflammatory, immunosuppressant | |||
| pharmacologic = Systemic corticosteroid | |||
| onset = Rapid IV onset; duration up to 1.5 days. | |||
| halflife = Biologic effect 18 to 36 hours. | |||
| routes = IV, IM | |||
| highalert = No | |||
| blackbox = None | |||
| antidote = None; taper. | |||
| pregnancy = Use only if needed. | |||
}} | |||
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;"> | <div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;"> | ||
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.'' | ''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.'' | ||
Latest revision as of 16:09, 17 June 2026
| Drug monograph · NCLEX study reference | |
| Trade names | Medrol, Solu-Medrol |
|---|---|
| Therapeutic class | Anti-inflammatory, immunosuppressant |
| Pharmacologic class | Systemic corticosteroid |
| Onset / peak / duration | Rapid IV onset; duration up to 1.5 days. |
| Half-life / level | Biologic effect 18 to 36 hours. |
| Routes | IV, IM |
| High-alert (ISMP) | No |
| Black box warning | None |
| Antidote / reversal | None; taper. |
| Pregnancy / lactation | Use only if needed. |
Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.
Methylprednisolone (brand names Medrol, Solu-Medrol) — Anti-inflammatory, immunosuppressant; Systemic corticosteroid.
Identification
- Therapeutic class: Anti-inflammatory, immunosuppressant.
- Pharmacologic class: Systemic corticosteroid.
Pharmacology
- Mechanism of action: Same corticosteroid action; available as a tapering oral dose pack and IV.
- Onset / peak / duration: Rapid IV onset; duration up to 1.5 days.
- Half-life / therapeutic level: Biologic effect 18 to 36 hours.
Clinical use
- Indications: Acute flares, severe inflammation, spinal cord injury protocols, transplant.
- Usual dose, route, frequency: Oral dose pack tapering schedule; IV or IM for acute use.
- Maximum dose / adjustments: Lowest effective dose; high-dose IV used short term.
Safety
- Contraindications: Systemic fungal infection.
- Black box warning: None.
- Interactions: Same as prednisone.
- Pregnancy / lactation: Use only if needed.
- High-alert: No.
Adverse effects
- Common side effects: Same corticosteroid effects.
- Serious effects to report: Hyperglycemia, infection, mood changes, GI bleeding.
- Antidote / reversal: None; taper.
Nursing process
- Assessment before administration: Glucose, infection, blood pressure.
- Interventions during therapy: Follow the dose pack exactly; give IV at the recommended rate.
- Monitor: Glucose, blood pressure, electrolytes, infection.
- Evaluation / expected outcome: Reduced acute inflammation.
Patient teaching
- Patient teaching: Follow the dose pack schedule precisely.
- Notify provider if: Signs of infection, severe mood changes.
- Administration tips: Oral with food; follow taper.